These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27717206)

  • 1. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
    Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
    Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
    Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
    Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
    Zhang T; Wan JG; Liu JB; Deng M
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
    Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
    Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.
    Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Status of
    Muñoz-Hidalgo L; San-Miguel T; Megías J; Serna E; Calabuig-Fariñas S; Monleón D; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
    Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
    Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Tryndyak VP; Beland FA; Pogribny IP
    Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells.
    Lobert S; Graichen ME; Morris K
    Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.